Associate Professor
The Chinese University of Hong Kong
Dr Jeremy Teoh is currently the Assistant Dean (External Affairs) and Associate Professor at The Chinese University of Hong Kong. He is also the Clinical Director of Urology, and Director of Robotic Services, at the CUHK Medical Centre. In 2021, he was awarded the Ten Outstanding Young Persons Award (Hong Kong) and the SIU-Innovators Award. In 2023, he was appointed as an Adjunct Professor at the Medical University of Vienna. In 2024, he received the World Chinese Urological Society Rising Star Award.
Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he developed a global consensus statement on en bloc resection of bladder tumour (ERBT), and it has become the standard reference for urologists practising en bloc resection globally. Recently, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm NMIBC. He is also leading a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm). He is currently serving as a panel member of the EAU Guidelines on NMIBC and UTUC.
Jeremy has received numerous research grants with a total funding of >15 million USD. He has published >500 articles in peer-reviewed journals such as European Urology and Nature Reviews Urology. He was the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021), the Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine (2021-2022), and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2017. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.
Disclosure information not submitted.
Friday, April 28, 2023
1:30 PM – 3:30 PM CST
Saturday, April 29, 2023
8:40 AM – 8:50 AM CST